Efficacy of the Memory Motivation (MEMO) Web Application Training

Study Overview
=================
Brief Summary
-----------------
Memory, attentional, and behavioural symptoms are the clinical hallmarks of Neurocognitive disorders (NCD) such as Alzheimer's disease and related disorders. The World Health Organisation (WHO) guidelines for risk reduction of cognitive decline and dementia indicate that Cognitive training may be offered to older adults with normal cognition and with mild cognitive impairment to reduce the risk of cognitive decline and/or dementia. The use of Information and Communication Technologies (ICT) in the health domain is progressively expanding. The Alzheimer Innovation Association have developed MeMo (Memory Motivation) a free web application that can be used at home by patients. The objective of the present study was to assess the effectiveness of employing the MeMo platform on cognitive performance in patients suffering from NCD.

Detailed Description
-----------------
The objective of this study is to evaluate the effectiveness of the MeMo cognitive training exercise platform in patients suffering from neurocognitive disorders. These exercises ,have been developed by the association Innovation Alzheimer and the CoBTeK research team, located with the Nice memory Center at the Institut Claude Pompidou. MeMo can be used freely at home by patients. More specifically, it is a randomized controlled study that aims to compare the evolution of activities cognition and behavior between patients not using these exercises, and patients using these exercises for 12 weeks, 4 sessions per week.

Official Title
-----------------
Efficacy of the Memory Motivation (MEMO) Web Application for Cognitive and Behavioral Training in Patients With Neurocognitive Disorders

Conditions
-----------------
Neurocognitive Disorders

Intervention / Treatment
-----------------
* Device: MeMo web application
* Other: Control group


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Outpatient consulting the Memory center older than 60 years old Mini Mental State examination score (MMSE) between 16 and 28 / 30 met the DSM 5 diagnoses of mild neurocognitive disorders (mild NCD) or major neurocognitive disorders (Major NCD). Exclusion Criteria: Patients not able to read and write French presence of a hearing or major visual impairment a history of premorbid mental retardation had already used the MeMo application were presently involved in structured memory training activities.

Ages Eligible for Study
-----------------
Minimum Age: 60 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Interventional Model Description: regular use of a web application at home to train cognition and behavior
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: MeMo group<br>MeMo group: experimental: regular use at home of the Memo web application In the Memo group patients were instructed on how to use the application, and allowed to train for 12 weeks. It was also explained that this training needed to be done regularly on a basis of 4 sessions of 30 minutes each per week. | Device: MeMo web application<br>* The patient betwenn 2 consultation could use the application MeMo. MeMo is a web application that can thus be used on any web browser (computer or tablet). On tablet, the application can be installed on home screen to look like a native app, and used offline.<br>|
| Placebo Comparator: Control group<br>Regular follow up at the memory center without cognitive training | Other: Control group<br>* the patient have the classical follow up at the memory center (consultation)<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change is being assessed with the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) | To score the IQCODE, add up the score for each question and divide by the number of questions. For the long IQCODE, divide by 26. | Base line, Week 12 | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change in attention is is being assessed with the DSST | Digit Symbol Substitution Test (attentional task) | Base line, Week 12 | 
| Change in frontal functioning is being assessed with the FAB | the Frontal Assessment Battery: Score 0 (healthy) - 18 (pathology) | Base line, Week 12 | 
| Change in behavior is being assessed with the NPI | Neuropsychiatric Inventory score 0 (healthy) - 134 (pathology) | Base line, Week 12 | 
| IA-C | Change in motivation is being assessed with theApathy inventory, clinician version score 0 (healthy)- 12 (pathology) | Base line, Week 12 | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Cognition, motivation, technology, non pharmacological intervention